Literature DB >> 20694869

Lifetime, low-dose ochratoxin A dietary study on renal carcinogenesis in male Fischer rats.

Peter Mantle1, Elena Kulinskaya.   

Abstract

Carcinoma arising from male rat renal parenchyma is an aspect of the nephrotoxicity of ochratoxin A (OTA) and is a factor in considering application of animal data to human health risk assessment. We present experimental data to complement already published and to complete dose-response findings for dietary OTA. From 34 rats, only four unilateral renal carcinomas (12%) developed during a 2-year exposure to dietary OTA, contaminated to give the same weekly overall dosage as in the 50 µg kg(-1) gavage-dosing regimen of an NTP study (30%). Statistical analysis included adjustment for premature leukaemia deaths, resulting in the carcinoma incidence of 35% (10-81%), and showed no significant difference from NTP (incidence of 43% (23-49%)) due to the smaller number of animals. However, absence of microscopic neoplastic renal lesions in premature decedents argues for minimal effect of the 47% leukaemia on carcinoma expression in the present experiment. This would fit with previously published findings showing significantly less carcinoma expression from a regimen administering an OTA dose in feed than was achieved by a lower dose by gavage as in the NTP study. It is concluded that chronic gavage administration of OTA to male rats may optimise carcinoma incidence for toxicological purposes, but that the dietary mode gives data more applicable to assessing putative health risk for humans.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20694869     DOI: 10.1080/19440049.2010.502302

Source DB:  PubMed          Journal:  Food Addit Contam Part A Chem Anal Control Expo Risk Assess        ISSN: 1944-0057


  10 in total

1.  Mycotoxins as human carcinogens-the IARC Monographs classification.

Authors:  Vladimir Ostry; Frantisek Malir; Jakub Toman; Yann Grosse
Journal:  Mycotoxin Res       Date:  2016-11-25       Impact factor: 3.833

2.  Pathological outcomes in kidney and brain in male Fischer rats given dietary ochratoxin A, commencing at one year of age.

Authors:  Peter G Mantle; Christopher C Nolan
Journal:  Toxins (Basel)       Date:  2010-05-13       Impact factor: 4.546

3.  H NMR spectroscopy-based metabolomic assessment of uremic toxicity, with toxicological outcomes, in male rats following an acute, mid-life insult from ochratoxin a.

Authors:  Peter G Mantle; Andrew W Nicholls; John P Shockcor
Journal:  Toxins (Basel)       Date:  2011-05-26       Impact factor: 4.546

Review 4.  A reassessment of risk associated with dietary intake of ochratoxin A based on a lifetime exposure model.

Authors:  Lois A Haighton; Barry S Lynch; Bernadene A Magnuson; Earle R Nestmann
Journal:  Crit Rev Toxicol       Date:  2012-02       Impact factor: 5.635

5.  Evaluating weight of evidence in the mystery of Balkan endemic nephropathy.

Authors:  Travis Bui-Klimke; Felicia Wu
Journal:  Risk Anal       Date:  2014-06-20       Impact factor: 4.000

Review 6.  Ochratoxin A: 50 Years of Research.

Authors:  Frantisek Malir; Vladimir Ostry; Annie Pfohl-Leszkowicz; Jan Malir; Jakub Toman
Journal:  Toxins (Basel)       Date:  2016-07-04       Impact factor: 4.546

7.  Immunohistochemical Analysis of Rat Renal Tumours Caused by Ochratoxin A.

Authors:  Diana Herman; Peter Mantle
Journal:  Toxins (Basel)       Date:  2017-11-28       Impact factor: 4.546

8.  Rat Kidney Cancers Determined by Dietary Ochratoxin A in the First Year of Life.

Authors:  Peter Mantle
Journal:  J Kidney Cancer VHL       Date:  2016-09-26

Review 9.  Immunohistochemical Review of Leydig Cell Lesions in Ochratoxin A-Treated Fischer Rats and Controls.

Authors:  Diana Herman; Peter Mantle
Journal:  Toxins (Basel)       Date:  2019-08-20       Impact factor: 4.546

10.  Comparative immunohistochemical analysis of ochratoxin A tumourigenesis in rats and urinary tract carcinoma in humans; mechanistic significance of p-S6 ribosomal protein expression.

Authors:  Patrycja Gazinska; Diana Herman; Cheryl Gillett; Sarah Pinder; Peter Mantle
Journal:  Toxins (Basel)       Date:  2012-09-11       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.